Perioperative management of pregnant women combined with congenital fibrinogen deficiency: four cases report and literature review.
- Author:
Chun Qing LI
1
;
Dong Xin WANG
1
;
Xiao Yu WEI
2
Author Information
1. Department of Anesthesiology, Peking University First Hospital, Beijing 100034, China.
2. Department of Gynaecology and Obstetrics, Peking University First Hospital, Beijing 100034, China.
- Publication Type:Review
- MeSH:
Afibrinogenemia/therapy*;
Blood Coagulation Tests;
Cesarean Section;
Female;
Fibrinogen;
Humans;
Partial Thromboplastin Time;
Pregnancy;
Pregnancy Complications/therapy*;
Thrombelastography
- From:
Journal of Peking University(Health Sciences)
2018;50(5):932-936
- CountryChina
- Language:Chinese
-
Abstract:
Congenital fibrinogen deficiency is an autosomal recessive or dominant disorder in which quantitative (afibrinogenaemia or hypofibrinogenaemia) or qualitative (dysfibrinogenaemia) defects in the fibrinogen Aa, Bb or c protein chains that lead to reduced functional fibrinogen. We now report the perioperative management of 4 pregnant women suffering from hypofibrinogenaemia scheduled for elective caesarean section from December 2012 to October 2016 in Peking University First Hospital and review this disease with reference to classification, symptom, replacement therapy, and selection of the modes of pregnancy termination and anesthesia. The four patients were all asymptomatic, whereas there existed recurrent pregnancy loss (case 3), family history (case 2), and offspring heredity (cases 3 and 4). Routine clotting studies revealed low fibrinogen levels and prolonged thrombin time (TT) during pregnancy and on admission. However, the platelet (PLT) count, prothrombin time (PT) and activated partial thromboplastin time (APTT) were normal. All the patients were administered fibrinogen concentrate perioperatively, and underwent uncomplicated combined spinal-epidural anesthesia and uneventful surgical procedure without postpartum hemorrhage. The replacement therapy of fibrinogen or fresh frozen plasma administration was essential to avoid anesthesia and obstetric complications. Regional blockade could safely be offered in the caesarean section, providing that their coagulation defect was corrected by availability of therapeutic products and adequate response to treatment. In addition, the point-of-care rotational thrombelastometry (ROTEM) or thrombelastogram (TEG) could play an important role in an optimal perioperative management for such patients. Management plans must be tailored to each individual, taking into consideration their bleeding risk as well as potential maternal and neonatal complications.
